Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 206

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.
About This Bill
Committee
Latest Action · January 20, 2023
Referred to the Subcommittee on Health.
Congress
118th (2023–2025)
Introduced
January 9, 2023
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
Healthy Technology Act of 2023 This bill establishes that artificial intelligence (AI) or machine learning technology may be eligible to prescribe drugs. Currently, certain drugs may be dispensed only upon a prescription provided by a practitioner licensed by law to administer the drug. Under this bill, an AI or machine learning technology may qualify as such a prescribing practitioner if the technology is (1) authorized by state law to prescribe the drug involved; and (2) approved, cleared, or authorized under certain federal provisions pertaining to medical devices and products.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.